CME/CE
Popular
Barbara O'Brien, MD
- MinuteCE®
First-Line Management of HR+/HER2-Low Breast Cancer With Brain Metastases
1.00 program creditBarbara O'Brien, MD
Nadia Harbeck, MD, PhD
- CME/CE In-Person & Virtual Event
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
May 30, 2026
Chicago, Illinois Mariana C. Castells, MD, PhD
Tsewang Tashi, MD
Charles E. Geyer Jr., MD, FACP
Komal Jhaveri, MD, FACP
Marlana Orloff, MD
Gregory Daniels, MD, PhD
Jesse Keller, MD
A.J. Gelderblom, MD, PhD
- MinuteCE®
Applying the Evidence: TGCT Treatment Insights for Sports Medicine Physicians
1.00 program creditA.J. Gelderblom, MD, PhD
Chelsea Cole, MD
- MinuteCE®
Beyond the Joint: Cross-Specialty Solutions for Advancing TGCT Patient Care
1.00 credit 10 episodesA.J. Gelderblom, MD, PhD
Michiel van de Sande, MD, PhD
Chelsea Cole, MD
- MinuteCE®
Patient Perspective: Navigating TGCT Treatment—Surgery vs Systemic Therapy
1.00 program creditA.J. Gelderblom, MD, PhD
A.J. Gelderblom, MD, PhD
- MinuteCE®
Emerging Evidence in Focus: Interpreting Data on Next-Generation CSF1R TKIs
1.00 program creditA.J. Gelderblom, MD, PhD
- MinuteCE®
Surgical Crossroads: Practical Considerations for Optimizing Treatment in TGCT
1.00 program creditA.J. Gelderblom, MD, PhD
Michiel van de Sande, MD, PhD
Giuseppe Curigliano, MD, PhD
- MinuteCE®
Doublet or Triplet? A Case-Based Debate in First-Line Choices for HR+/HER2- mBC
1.00 program creditGiuseppe Curigliano, MD, PhD
Komal Jhaveri, MD, FACP
Komal Jhaveri, MD, FACP
